Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Department of Neurosurgery, Haaglanden Medical Center and Leiden University Medical Center, The Hague, The Netherlands.
Acta Neurochir (Wien). 2021 Mar;163(3):661-676. doi: 10.1007/s00701-020-04544-x. Epub 2020 Sep 5.
The gold-standard treatment for symptomatic anterior skull base meningiomas is surgical resection. The endoscope-assisted supraorbital "keyhole" approach (eSKA) is a promising technique for surgical resection of olfactory groove (OGM) and tuberculum sellae meningioma (TSM) but has yet to be compared with the microscopic transcranial (mTCA) and the expanded endoscopic endonasal approach (EEA) in the context of existing literature.
An updated study-level meta-analysis on surgical outcomes and complications of OGM and TSM operated with the eSKA, mTCA, and EEA was conducted using random-effect models.
A total of 2285 articles were screened, yielding 96 studies (2191 TSM and 1510 OGM patients). In terms of effectiveness, gross total resection incidence was highest in mTCA (89.6% TSM, 91.1% OGM), followed by eSKA (85.2% TSM, 84.9% OGM) and EEA (83.9% TSM, 82.8% OGM). Additionally, the EEA group had the highest incidence of visual improvement (81.9% TSM, 54.6% OGM), followed by eSKA (65.9% TSM, 52.9% OGM) and mTCA (63.9% TSM, 45.7% OGM). However, in terms of safety, the EEA possessed the highest cerebrospinal fluid leak incidence (9.2% TSM, 14.5% OGM), compared with eSKA (2.1% TSM, 1.6% OGM) and mTCA (1.6% TSM, 6.5% OGM). Finally, mortality and intraoperative arterial injury were 1% or lower across all subgroups.
In the context of diverse study populations, the eSKA appeared not to be associated with increased adverse outcomes when compared with mTCA and EEA and offered comparable effectiveness. Case-selection is paramount in establishing a role for the eSKA in anterior skull base tumours.
对于有症状的前颅底脑膜瘤,金标准治疗方法是手术切除。内窥镜辅助眶上“钥匙孔”入路(eSKA)是一种有前途的手术切除嗅沟(OGM)和鞍结节脑膜瘤(TSM)的技术,但尚未在现有文献中与显微镜经颅(mTCA)和扩大经鼻内镜入路(EEA)进行比较。
使用随机效应模型对采用 eSKA、mTCA 和 EEA 手术治疗 OGM 和 TSM 的手术结果和并发症进行了更新的研究水平荟萃分析。
共筛选了 2285 篇文章,得到了 96 项研究(2191 例 TSM 和 1510 例 OGM 患者)。在有效性方面,mTCA 的大体全切除发生率最高(89.6% TSM,91.1% OGM),其次是 eSKA(85.2% TSM,84.9% OGM)和 EEA(83.9% TSM,82.8% OGM)。此外,EEA 组的视力改善发生率最高(81.9% TSM,54.6% OGM),其次是 eSKA(65.9% TSM,52.9% OGM)和 mTCA(63.9% TSM,45.7% OGM)。然而,在安全性方面,EEA 的脑脊液漏发生率最高(9.2% TSM,14.5% OGM),其次是 eSKA(2.1% TSM,1.6% OGM)和 mTCA(1.6% TSM,6.5% OGM)。最后,所有亚组的死亡率和术中动脉损伤均为 1%或更低。
在不同的研究人群中,与 mTCA 和 EEA 相比,eSKA 似乎不会增加不良后果,并且具有相当的疗效。病例选择对于在颅前底肿瘤中建立 eSKA 的作用至关重要。